Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Perineural Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity on Block Performance Time, Failure Rate and Incidence of Acute Complications
1 other identifier
observational
249
1 country
1
Brief Summary
Axillary brachial plexus block (freezing the nerves in armpit) is commonly performed as a primary anesthetic technique for the elbow/ forearm or hand surgery. These nerves are identified using ultrasound and nerve stimulator (by stimulating the nerves using a small current through the needle). Axillary brachial plexus block has been shown to result in better pain relief, less nausea, vomiting and early discharge from hospital. The use of these nerve blocks have also shown to decrease the duration of hospital stay, decreased side effects of opioids painkillers and better satisfaction scores over the conventional use of intravenous and oral pain medications. These beneficial effects are particularly useful for patients who are overweight or obese. A study by Hauouz et al published in Anesthesia and Analgesia in July 2010 suggests that the success rate of brachial plexus block is lower for obese and overweight patients. However, ultrasound guidance was not used for performing axillary brachial plexus block in this study. We propose that with usage of ultrasound guidance the success rate of brachial plexus block will be similar in obese and non-obese patients. In this study, we want to compare the success rate of axillary brachial plexus block for obese and non-obese patient groups. We would also like to look at performance time, complications and patient satisfaction for our study population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 9, 2014
CompletedFirst Posted
Study publicly available on registry
January 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedJuly 11, 2019
July 1, 2019
4.6 years
January 9, 2014
July 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Block success rate at 30 minutes
30 minutes after block performance
Secondary Outcomes (2)
Block performance time
Immediate
Incidence of acute complications
Immediate and 48 hours after block performance
Study Arms (2)
Patients with BMI less than 30 kg/m2
Patients with BMI less than 30 kg/m2 undergoing surgical procedures on upper limb (elbow, forearm and hand) scheduled to receive ultrasound-guided axillary brachial plexus block as their primary anesthetic modality at SJHC.
Patients with BMI 30 or above
Patients with BMI 30 kg/m2 undergoing surgical procedures on upper limb (elbow, forearm and hand) scheduled to receive ultrasound-guided axillary brachial plexus block as their primary anesthetic modality at SJHC
Interventions
Ultrasound guided axillary brachial plexus block
Eligibility Criteria
Patients undergoing surgical procedures on upper limb (elbow, forearm and hand) scheduled to receive ultrasound-guided axillary brachial plexus block as their primary anesthetic modality at SJHC
You may qualify if:
- Patients undergoing surgical procedures on upper limb (elbow, forearm and hand) scheduled to receive ultrasound-guided axillary brachial plexus block as their primary anesthetic modality at SJHC
- American Society of -Anaesthesiologists' (ASA) status I to III
You may not qualify if:
- Patients with associated significant cardiac and respiratory disease (ASA status 4/5)
- Patients with coexisting hematological disorder or with deranged coagulation parameters.
- Patients with pre-existing major organ dysfunction such as hepatic and renal failure.
- Psychiatric illnesses
- Emergency surgery
- Lack of informed consent.
- Allergy to any of the drugs used in the study
- Contraindications to brachial plexus block
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Joseph's Health Care
London, Ontario, N6A 4V2, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shalini Dhir, FRCPC
Lawson Health Research Institute & Western University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 9, 2014
First Posted
January 10, 2014
Study Start
September 1, 2013
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
July 11, 2019
Record last verified: 2019-07